Wolverine Asset Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

Wolverine Asset Management’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11,862	Closed	-$208K	–	2565
2021 Q3	$208K	Buy	+11,862	New	+$139K	﹤0.01%	1163

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Wolverine Asset Management's TRIL Position: Q4 2021 in Review

Wolverine Asset Management sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 11,862 shares — an estimated $208K sold.

Wolverine Asset Management first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $208K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Wolverine Asset Management reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Wolverine Asset Management sold 11,862 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $208K.
Wolverine Asset Management first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
Wolverine Asset Management's Trillium Therapeutics Inc. position peaked at $208K in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Wolverine Asset Management's 13F filing for Q4 2021, filed 9 Feb 2022.